Inhibition of JNK/c-Jun-ATF2 Overcomes Cisplatin Resistance in Liver Cancer through down-Regulating Galectin-1

Due to drug resistance, the clinical response to cisplatin (CDDP) from patients with liver cancer is unsatisfactory. The alleviation or overcoming of CDDP resistance is an urgent problem to be solved in clinics. Tumor cells rapidly change signal pathways to mediate drug resistance under drug exposur...

Descripción completa

Detalles Bibliográficos
Autores principales: Yang, Fan, Li, Mengzhu, Xu, Duo, Jiang, Zebo, Jiang, Hailong, Xiao, Yitai, Mei, Chaoming, Yang, Meilin, Chen, Congmin, Zhou, Bin, He, Bailiang, Shan, Hong, Pang, Pengfei, Li, Dan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Ivyspring International Publisher 2023
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10197891/
https://www.ncbi.nlm.nih.gov/pubmed/37215991
http://dx.doi.org/10.7150/ijbs.79163

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10197891/
https://www.ncbi.nlm.nih.gov/pubmed/37215991
http://dx.doi.org/10.7150/ijbs.79163

Ejemplares similares